Consensus AB Science

Equities

AB

FR0010557264

Market Closed - Euronext Paris Other stock markets 11:35:14 2024-05-29 am EDT			5-day change	1st Jan Change
1.95 ^EUR	-1.12%		-7.80%	-45.15%

May. 30	Transcript : AB Science S.A. - Special Call
May. 29	AB Science: towards a negative opinion from the CHMP, listing suspended	CF

Evolution of the average Target Price on AB Science

Price target over the last 5 years

History of analyst recommendation changes

8a4ef0ea3ca95b69825cc7d550cc752d.P8l4eizwn_mx3K3DftLRrRzNkh4J5oCLfbMl5FC79wU.B6E6CBSDrrTXheWEGrmUwE-rq1FDteLhRctDvmf4pUZ6_EEwasj3z_y46A~c14f4da128cb26f57f94ab4d27131e72

Analyst Recommendations on AB Science

AB Science : Masitinib Treatment Against Pancreatic Cancer Boosts Survival Rates	20-12-04	MT
SCIENCE : AB Science: Chardan Capital Markets initiates coverage with a BUY recommendation on AB Science and a target price of €30	15-05-05	GL

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.95 EUR

Average target price

6.895 EUR

Spread / Average Target

+253.59%

High Price Target

10 EUR

Spread / Highest target

+412.82%

Low Price Target

3.79 EUR

Spread / Lowest Target

+94.36%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar